News from the pharmaceutical and medical industry

Delivering Insulin a Focus of Numerous and Diverse Product Development Efforts

2010-01-26 (Amherst, NH) - A significant number of programs focused on alternative insulin
delivery technologies continue to move through the clinical development process.
In terms of the range of formulation strategies and delivery technologies,
alternative insulin delivery products currently in the pipeline represent the most
diverse population of drug candidates of any prescription drug. All of these
development-stage products share the common goal of reaping commercial success by
creating patient-friendly insulin delivery methods that address the preference and
compliance issues associated with traditional injection delivery methods.

A new report examines the implications of alternative insulin delivery on the
diabetes management sector. Delivering Insulin: the Current Market and the Next
Generation contains analysis of development-stage insulin products, assessments of
market, technology and demand factors, and profiles of formulation and delivery
technology companies.

More information is available at www.greystoneassociates.org .

submitted by Greystone Associates

Current news from the medical and pharmaceutical industry

Shire Announces European Approval of VPRIV® (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease

2010-08-27 Cambridge, MA, US – August, 27th 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty .. more ..

Industry Leaders Join Forces to Launch the New Voice of UK Life Sciences

2010-02-08 Live Webcast: 24th February, 12 noon Register at MedilinkUK.com A new website, billed as ‘THE V.. more ..

Clinical Solutions focuses on tech roll out with new appointment

2010-02-03 February 2010 - Clinical Solutions, the leading clinical decision support provider, has appointed Ri.. more ..

Past Headlines

|| 2010/08 | 2010/07 | 2010/06 | 2010/05 ||

Submit/manage news